Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell diseaseErsi Voskaridou, Dimitris Loukopoulos, Maroussa Douskou et al.|British Journal of Haematology|2004Cited by 148
Early markers of renal dysfunction in patients with sickle cell/β-thalassemiaErsi Voskaridou, Ioannis Papassotiriou, D. Simirloglou et al.|Kidney International|2006Cited by 76
Deferiprone as an oral iron chelator in sickle cell diseaseErsi Voskaridou, Dimitris Loukopoulos, Maroussa Douskou et al.|Annals of Hematology|2005Cited by 36
Increased erythropoietin level induced by hydroxyurea treatment of sickle cell patientsIoannis Papassotiriou, Dimitris Loukopoulos, Ersi Voskaridou et al.|The Hematology Journal|2000Cited by 18
Hb Arta [β45 (CD4) Phe→Cys]: a new unstable haemoglobin with reduced oxygen affinity in trans with β‐thalassaemiaGeorge Vassilopoulos, Dimitris Loukopoulos, Ioannis Papassotiriou et al.|British Journal of Haematology|1995Cited by 15